H3C7: A Potential Drug Target and Biomarker for Various Diseases

H3C7: A Potential Drug Target and Biomarker for Various Diseases

H3C7, also known as H3C2, is a protein that is expressed in various tissues of the body, including the brain, lungs, heart, kidneys, and liver. It is a member of the H3 cytosome, which is a complex of histone proteins that play a crucial role in cell signaling and gene expression.

H3C7 has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and subcellular localization have made it an attractive target for small molecule inhibitors.

One of the key reasons for the interest in H3C7 is its role in various physiological processes. H3C7 is involved in the regulation of cell division, cell adhesion, and cell signaling. It has been shown to play a critical role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

For example, H3C7 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles and neuroglial cells. H3C7 has been shown to be involved in the regulation of neurogenesis, which is the process by which new neurons are generated in the brain.

In addition to its role in neurodegenerative diseases, H3C7 has also been shown to be involved in the development of cancer. Cancer is a complex disease that is characterized by the rapid and uncontrolled growth of cells. H3C7 has been shown to play a critical role in the regulation of cell growth and the development of cancer.

One of the key mechanisms by which H3C7 is involved in cancer is its role in the regulation of cell signaling. H3C7 has been shown to play a critical role in the regulation of signaling pathways that are involved in cell growth, differentiation, and survival. Its involvement in these signaling pathways makes it an attractive target for small molecule inhibitors.

Another mechanism by which H3C7 is involved in cancer is its role in the regulation of cell division. Cancer is characterized by the rapid and uncontrolled growth of cells, and H3C7 has been shown to play a critical role in the regulation of cell division. Its involvement in this process makes it an attractive target for small molecule inhibitors that can inhibit cell proliferation.

In addition to its involvement in cancer, H3C7 has also been shown to be involved in the regulation of other physiological processes. H3C7 is involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs. Its involvement in this process makes it an attractive target for small molecule inhibitors that can inhibit cell adhesion.

H3C7 has also been shown to play a critical role in the regulation of cell signaling. Its involvement in signaling pathways that are involved in cell survival and angiogenesis makes it an attractive target for small molecule inhibitors.

Overall, H3C7 is a protein that has significant involvement in various physiological processes. Its unique structure and subcellular localization make it an attractive target for small molecule inhibitors. Further research is needed to fully understand the role of H3C7 in various diseases and to develop effective treatments.

Protein Name: H3 Clustered Histone 7

Functions: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling

The "H3C7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about H3C7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

H3C8 | H3P16 | H3P36 | H3P37 | H3P44 | H3P5 | H3P6 | H4C1 | H4C11 | H4C12 | H4C13 | H4C14 | H4C15 | H4C16 | H4C2 | H4C3 | H4C4 | H4C5 | H4C6 | H4C7 | H4C8 | H4C9 | H6PD | HAAO | HABP2 | HABP4 | HACD1 | HACD2 | HACD3 | HACD4 | HACE1 | HACL1 | HADH | HADHA | HADHAP1 | HADHB | HAFML | HAGH | HAGHL | HAGLR | HAGLROS | HAL | HAMP | HAND1 | HAND2 | HAND2-AS1 | HAO1 | HAO2 | HAO2-IT1 | HAP1 | HAPLN1 | HAPLN2 | HAPLN3 | HAPLN4 | HAPSTR1 | HAR1A | HAR1B | HARBI1 | HARS1 | HARS2 | HAS1 | HAS2 | HAS2-AS1 | HAS3 | HASPIN | HAT1 | HAUS1 | HAUS1P1 | HAUS2 | HAUS3 | HAUS4 | HAUS5 | HAUS6 | HAUS7 | HAUS8 | HAVCR1 | HAVCR1P1 | HAVCR2 | HAX1 | HAX1P1 | HBA1 | HBA2 | HBAP1 | HBB | HBBP1 | HBD | HBE1 | HBEGF | HBG1 | HBG2 | HBM | HBO1 complex | HBP1 | HBQ1 | HBS1L | HBZ | HBZP1 | HCAR1 | HCAR2 | HCAR3